Brussels, 5 June 2026 - EuropaBio welcomes the Baker Company Benelux BV as its newest member.

Founded in Sanford, Maine (USA), The Baker Company Benelux BV specialises in precision cell culture, containment technologies and solutions supporting advanced therapies and biomanufacturing.

The Baker aims to further contribute its scientific and technical expertise to support innovation, manufacturing resilience and the development of advanced therapies in Europe.

In joining EuropaBio, The Baker seeks to strengthen its engagement at European level, contribute to policy discussions, and actively participate in cross-sectoral dialogue shaping the future of biotechnology.

Dr. Claire Skentelbery, Director General of EuropaBio, said: “The Baker Company becoming part of EuropaBio confirms again that biomanufacturing represents European innovators through the whole value chain. We are delighted that we can bring the voice of The Baker Company into the core of our work.”

Dr. Krista Rantanen, Director of Global Business Development, Advanced Life Science Markets at the Baker Company Benelux BV, said: "We are excited to join EuropaBio and contribute to the collective effort of advancing biotechnology innovation and resilient biomanufacturing in Europe. At The Baker Company, we are committed to supporting the scientific community with technologies that enable the safe and reproducible development of advanced therapies for the benefit of patients worldwide."